1 Study Coverage 1.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Product Introduction 1.2 Market by Type 1.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate by Type 1.2.2 Bevacizumab 1.2.3 Ranibizumab 1.2.4 Aflibercept 1.2.5 Others 1.3 Market by Application 1.3.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate by Application 1.3.2 Hospitals 1.3.3 Specialty Clinics 1.3.4 Ambulatory Surgical Centers 1.3.5 Cancer Research Institutes 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size, Estimates and Forecasts 2.1.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue 2016-2027 2.1.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales 2016-2027 2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Historical Market Size by Region (2016-2021) 2.3.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Vascular Endothelial Growth Factor (VEGF) Antibodies Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Region (2022-2027) 2.4.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Forecast by Region (2022-2027) 3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Competitor Landscape by Players 3.1 Global Top Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers by Sales 3.1.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Manufacturer (2016-2021) 3.1.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers by Revenue 3.2.1 Key Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers Covered: Ranking by Revenue 3.2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Manufacturers (2016-2021) 3.2.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue in 2020 3.2.6 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Manufacturers 3.4 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturing Base Distribution, Product Types 3.4.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Vascular Endothelial Growth Factor (VEGF) Antibodies Product Type 3.4.3 Date of International Manufacturers Enter into Vascular Endothelial Growth Factor (VEGF) Antibodies Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Type (2016-2021) 4.1.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2021) 4.1.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2016-2021) 4.1.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Type (2022-2027) 4.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Type (2022-2027) 4.2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Forecast by Type (2022-2027) 4.2.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Application (2016-2021) 5.1.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2021) 5.1.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2016-2021) 5.1.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2016-2021) 5.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Application (2022-2027) 5.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Application (2022-2027) 5.2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Forecast by Application (2022-2027) 5.2.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size YoY Growth 2016-2027 6.1.1 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales YoY Growth 2016-2027 6.1.2 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue YoY Growth 2016-2027 6.1.3 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share in Global Market 2016-2027 6.2 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Players (International and Local Players) 6.2.1 Japan Top Vascular Endothelial Growth Factor (VEGF) Antibodies Players by Sales (2016-2021) 6.2.2 Japan Top Vascular Endothelial Growth Factor (VEGF) Antibodies Players by Revenue (2016-2021) 6.3 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Historic Market Review by Type (2016-2021) 6.3.1 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2016-2021) 6.3.2 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Type (2016-2021) 6.3.3 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2016-2021) 6.4 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Type (2022-2027) 6.4.2 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Forecast by Type (2022-2027) 6.4.3 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Price Forecast by Type (2022-2027) 6.5 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Historic Market Review by Application (2016-2021) 6.5.1 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2016-2021) 6.5.2 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Application (2016-2021) 6.5.3 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2016-2021) 6.6 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Application (2022-2027) 6.6.2 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Forecast by Application (2022-2027) 6.6.3 Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Price Forecast by Application (2022-2027) 7 North America 7.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size YoY Growth 2016-2027 7.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Facts & Figures by Country 7.2.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021) 7.2.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size YoY Growth 2016-2027 8.2 Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Facts & Figures by Region 8.2.1 Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2016-2021) 8.2.2 Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size YoY Growth 2016-2027 9.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Facts & Figures by Country 9.2.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021) 9.2.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size YoY Growth 2016-2027 10.2 Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Facts & Figures by Country 10.2.1 Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021) 10.2.2 Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Facts & Figures by Country 11.2.1 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021) 11.2.2 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Roche 12.1.1 Roche Corporation Information 12.1.2 Roche Description and Business Overview 12.1.3 Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.1.5 Roche Recent Development 12.2 Novartis 12.2.1 Novartis Corporation Information 12.2.2 Novartis Description and Business Overview 12.2.3 Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.2.5 Novartis Recent Development 12.3 Sanofi 12.3.1 Sanofi Corporation Information 12.3.2 Sanofi Description and Business Overview 12.3.3 Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.3.5 Sanofi Recent Development 12.4 Regeneron 12.4.1 Regeneron Corporation Information 12.4.2 Regeneron Description and Business Overview 12.4.3 Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.4.5 Regeneron Recent Development 12.5 Bayer 12.5.1 Bayer Corporation Information 12.5.2 Bayer Description and Business Overview 12.5.3 Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.5.5 Bayer Recent Development 12.6 AstraZeneca 12.6.1 AstraZeneca Corporation Information 12.6.2 AstraZeneca Description and Business Overview 12.6.3 AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.6.4 AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.6.5 AstraZeneca Recent Development 12.7 Pfizer 12.7.1 Pfizer Corporation Information 12.7.2 Pfizer Description and Business Overview 12.7.3 Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.7.5 Pfizer Recent Development 12.8 Merck 12.8.1 Merck Corporation Information 12.8.2 Merck Description and Business Overview 12.8.3 Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.8.5 Merck Recent Development 12.9 Eli Lilly 12.9.1 Eli Lilly Corporation Information 12.9.2 Eli Lilly Description and Business Overview 12.9.3 Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.9.5 Eli Lilly Recent Development 12.10 GlaxoSmithKline 12.10.1 GlaxoSmithKline Corporation Information 12.10.2 GlaxoSmithKline Description and Business Overview 12.10.3 GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.10.4 GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.10.5 GlaxoSmithKline Recent Development 12.11 Roche 12.11.1 Roche Corporation Information 12.11.2 Roche Description and Business Overview 12.11.3 Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Products Offered 12.11.5 Roche Recent Development 12.12 Boehringer Ingelheim 12.12.1 Boehringer Ingelheim Corporation Information 12.12.2 Boehringer Ingelheim Description and Business Overview 12.12.3 Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Boehringer Ingelheim Products Offered 12.12.5 Boehringer Ingelheim Recent Development 12.13 Abcam Plc 12.13.1 Abcam Plc Corporation Information 12.13.2 Abcam Plc Description and Business Overview 12.13.3 Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Abcam Plc Products Offered 12.13.5 Abcam Plc Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Trends 13.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Market Drivers 13.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Market Challenges 13.4 Vascular Endothelial Growth Factor (VEGF) Antibodies Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Bevacizumab Table 3. Major Manufacturers of Ranibizumab Table 4. Major Manufacturers of Aflibercept Table 5. Major Manufacturers of Others Table 6. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate by Application (2021-2027) & (K Units) Table 7. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Regions (2016-2021) & (K Units) Table 9. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Regions (2016-2021) Table 10. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Region (2022-2027) & (K Units) Table 12. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share Forecast by Region (2022-2027) Table 13. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share Forecast by Region (2022-2027) Table 15. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Manufacturers (2016-2021) (K Units) Table 16. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers by Revenue (US$ Million) in 2020 Table 18. Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Manufacturers (2016-2021) Table 20. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global Vascular Endothelial Growth Factor (VEGF) Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vascular Endothelial Growth Factor (VEGF) Antibodies as of 2020) Table 22. Key Manufacturers Vascular Endothelial Growth Factor (VEGF) Antibodies Price (2016-2021) (US$/Unit) Table 23. Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Vascular Endothelial Growth Factor (VEGF) Antibodies Product Type Table 25. Date of International Manufacturers Enter into Vascular Endothelial Growth Factor (VEGF) Antibodies Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2021) (K Units) Table 28. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Type (2016-2021) Table 29. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2016-2021) (US$ Million) Table 30. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Type (2016-2021) Table 31. Vascular Endothelial Growth Factor (VEGF) Antibodies Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 32. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Type (2022-2027) & (K Units) Table 33. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share Forecast by Type (2022-2027) Table 34. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share Forecast by Type (2022-2027) Table 36. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 37. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2021) (K Units) Table 38. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Application (2016-2021) Table 39. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2016-2021) (US$ Million) Table 40. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Application (2016-2021) Table 41. Vascular Endothelial Growth Factor (VEGF) Antibodies Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 42. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Application (2022-2027) & (K Units) Table 43. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share Forecast by Application (2022-2027) Table 44. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share Forecast by Application (2022-2027) Table 46. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 47. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units) of Key Companies (2016-2021) Table 48. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Company (2016-2021) Table 49. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (US$ Million) by Company (2016-2021) Table 50. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Company (2016-2021) Table 51. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units) by Type (2016-2021) Table 52. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Type (2016-2021) Table 53. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Price (US$/Unit) by Type (2016-2021) Table 55. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units) by Type (2022-2027) Table 56. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Type (2022-2027) Table 57. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Type (2022-2027) Table 59. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Price (US$/Unit) by Type (2022-2027) Table 60. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units) by Application (2016-2021) Table 61. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Application (2016-2021) Table 62. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Price (US$/Unit) by Application (2016-2021) Table 64. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units) by Application (2022-2027) Table 65. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Application (2022-2027) Table 66. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Application (2022-2027) Table 68. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Price (US$/Unit) by Application (2022-2027) Table 69. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021) & (K Units) Table 70. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2016-2021) Table 71. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021) & (US$ Million) Table 72. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2016-2021) & (K Units) Table 74. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region (2016-2021) Table 75. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region (2016-2021) Table 77. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021) & (K Units) Table 78. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2016-2021) Table 79. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country (2016-2021) Table 81. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021) & (K Units) Table 82. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2016-2021) Table 83. Latin Americaa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021) & (K Units) Table 86. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country (2016-2021) Table 89. Roche Corporation Information Table 90. Roche Description and Business Overview Table 91. Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 92. Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Product Table 93. Roche Recent Development Table 94. Novartis Corporation Information Table 95. Novartis Description and Business Overview Table 96. Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 97. Novartis Product Table 98. Novartis Recent Development Table 99. Sanofi Corporation Information Table 100. Sanofi Description and Business Overview Table 101. Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 102. Sanofi Product Table 103. Sanofi Recent Development Table 104. Regeneron Corporation Information Table 105. Regeneron Description and Business Overview Table 106. Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 107. Regeneron Product Table 108. Regeneron Recent Development Table 109. Bayer Corporation Information Table 110. Bayer Description and Business Overview Table 111. Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 112. Bayer Product Table 113. Bayer Recent Development Table 114. AstraZeneca Corporation Information Table 115. AstraZeneca Description and Business Overview Table 116. AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 117. AstraZeneca Product Table 118. AstraZeneca Recent Development Table 119. Pfizer Corporation Information Table 120. Pfizer Description and Business Overview Table 121. Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 122. Pfizer Product Table 123. Pfizer Recent Development Table 124. Merck Corporation Information Table 125. Merck Description and Business Overview Table 126. Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 127. Merck Product Table 128. Merck Recent Development Table 129. Eli Lilly Corporation Information Table 130. Eli Lilly Description and Business Overview Table 131. Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 132. Eli Lilly Product Table 133. Eli Lilly Recent Development Table 134. GlaxoSmithKline Corporation Information Table 135. GlaxoSmithKline Description and Business Overview Table 136. GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 137. GlaxoSmithKline Product Table 138. GlaxoSmithKline Recent Development Table 139. Bristol-Myer Squibb Corporation Information Table 140. Bristol-Myer Squibb Description and Business Overview Table 141. Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 142. Bristol-Myer Squibb Product Table 143. Bristol-Myer Squibb Recent Development Table 144. Boehringer Ingelheim Corporation Information Table 145. Boehringer Ingelheim Description and Business Overview Table 146. Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 147. Boehringer Ingelheim Product Table 148. Boehringer Ingelheim Recent Development Table 149. Abcam Plc Corporation Information Table 150. Abcam Plc Description and Business Overview Table 151. Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 152. Abcam Plc Product Table 153. Abcam Plc Recent Development Table 154. Vascular Endothelial Growth Factor (VEGF) Antibodies Market Trends Table 155. Vascular Endothelial Growth Factor (VEGF) Antibodies Market Drivers Table 156. Vascular Endothelial Growth Factor (VEGF) Antibodies Market Challenges Table 157. Vascular Endothelial Growth Factor (VEGF) Antibodies Market Restraints Table 158. Vascular Endothelial Growth Factor (VEGF) Antibodies Customers List Table 159. Vascular Endothelial Growth Factor (VEGF) Antibodies Distributors List Table 160. Research Programs/Design for This Report Table 161. Key Data Information from Secondary Sources Table 162. Key Data Information from Primary Sources List of Figures Figure 1. Vascular Endothelial Growth Factor (VEGF) Antibodies Product Picture Figure 2. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type in 2020 & 2027 Figure 3. Bevacizumab Product Picture Figure 4. Ranibizumab Product Picture Figure 5. Aflibercept Product Picture Figure 6. Others Product Picture Figure 7. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application in 2020 & 2027 Figure 8. Hospitals Figure 9. Specialty Clinics Figure 10. Ambulatory Surgical Centers Figure 11. Cancer Research Institutes Figure 12. Others Figure 13. Vascular Endothelial Growth Factor (VEGF) Antibodies Report Years Considered Figure 14. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size 2016-2027 (US$ Million) Figure 16. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales 2016-2027 (K Units) Figure 17. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Market Share by Region: 2021 Versus 2027 Figure 18. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region (2016-2021) Figure 19. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region in 2020 Figure 20. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region (2016-2021) Figure 21. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region in 2020 Figure 22. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Manufacturer in 2020 Figure 23. The Top 10 and 5 Players Market Share by Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue in 2020 Figure 24. Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 25. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2016-2021) Figure 26. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type in 2020 Figure 27. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Type (2016-2021) Figure 28. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Type in 2020 Figure 29. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2016-2021) Figure 30. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application in 2020 Figure 31. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Application (2016-2021) Figure 32. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Application in 2020 Figure 33. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate 2016-2027 (K Units) Figure 34. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate 2016-2027 (US$ Million) Figure 35. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share in Global Market 2016-2027 Figure 36. Japan 5 and 10 Largest Vascular Endothelial Growth Factor (VEGF) Antibodies Players Market Share by Revenue in Vascular Endothelial Growth Factor (VEGF) Antibodies in 2020 Figure 37. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Type (2016-2021) Figure 38. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate by Type in 2016 & 2020 Figure 39. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Application (2016-2021) Figure 40. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate by Application in 2016 & 2020 Figure 41. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate 2016-2021 (K Units) Figure 42. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate 2016-2021 (US$ Million) Figure 43. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country in 2020 Figure 44. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country in 2020 Figure 45. U.S. Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 46. U.S. Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Canada Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 48. Canada Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate 2016-2021 (K Units) Figure 50. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate 2016-2021 (US$ Million) Figure 51. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country in 2020 Figure 52. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country in 2020 Figure 53. Germany Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 54. Germany Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. France Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 56. France Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. U.K. Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 58. U.K. Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Italy Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 60. Italy Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Russia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 62. Russia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 63. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate 2016-2021 (K Units) Figure 64. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate 2016-2021 (US$ Million) Figure 65. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region in 2020 Figure 66. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region in 2020 Figure 67. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 68. China Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 70. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. South Korea Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 72. South Korea Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. India Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 74. India Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Australia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 76. Australia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Taiwan Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 78. Taiwan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Indonesia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 80. Indonesia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Thailand Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 82. Thailand Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Malaysia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 84. Malaysia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Philippines Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 86. Philippines Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Vietnam Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 88. Vietnam Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 89. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate 2016-2021 (K Units) Figure 90. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate 2016-2021 (US$ Million) Figure 91. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country in 2020 Figure 92. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country in 2020 Figure 93. Mexico Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 94. Mexico Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Brazil Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 96. Brazil Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Argentina Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 98. Argentina Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 99. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate 2016-2021 (K Units) Figure 100. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate 2016-2021 (US$ Million) Figure 101. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country in 2020 Figure 102. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country in 2020 Figure 103. Turkey Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 104. Turkey Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 106. Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. UAE Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (2016-2021) (K Units) Figure 108. UAE Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Growth Rate (2016-2021) (US$ Million) Figure 109. Vascular Endothelial Growth Factor (VEGF) Antibodies Value Chain Figure 110. Channels of Distribution Figure 111. Distributors Profiles Figure 112. Bottom-up and Top-down Approaches for This Report Figure 113. Data Triangulation Figure 114. Key Executives Interviewed

Roche Novartis Sanofi Regeneron Bayer AstraZeneca Pfizer Merck Eli Lilly GlaxoSmithKline Bristol-Myer Squibb Boehringer Ingelheim Abcam Plc